Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Short term Debt (2020 - 2025)

Maravai Lifesciences Holdings has reported Short term Debt over the past 6 years, most recently at $5.4 million for Q4 2025.

  • Quarterly results put Short term Debt at $5.4 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $5.4 million (changed 0.0% YoY), and the annual figure for FY2025 was $5.4 million, changed 0.0%.
  • Short term Debt for Q4 2025 was $5.4 million at Maravai Lifesciences Holdings, roughly flat from $5.4 million in the prior quarter.
  • Over the last five years, Short term Debt for MRVI hit a ceiling of $34.8 million in Q4 2021 and a floor of $1.3 million in Q1 2021.
  • Median Short term Debt over the past 5 years was $5.4 million (2022), compared with a mean of $9.7 million.
  • Peak annual rise in Short term Debt hit 2576.96% in 2022, while the deepest fall reached 84.38% in 2022.
  • Maravai Lifesciences Holdings' Short term Debt stood at $34.8 million in 2021, then plummeted by 84.38% to $5.4 million in 2022, then changed by 0.0% to $5.4 million in 2023, then changed by 0.0% to $5.4 million in 2024, then changed by 0.0% to $5.4 million in 2025.
  • The last three reported values for Short term Debt were $5.4 million (Q4 2025), $5.4 million (Q3 2025), and $5.4 million (Q2 2025) per Business Quant data.